Global Dermal Toxicity Testing Market Size To Exceed USD 4.95 Billion By 2033 | CAGR of 8.11%

The Global Dermal Toxicity Testing Market Size was Valued at USD 2.27 Billion in 2023 and the Worldwide Dermal Toxicity Testing Market Size is Expected to Reach USD 4.95 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: SGS S.A., Eurofins Scientific Inc, Qiagen N.V., Charles River Laboratories International, Inc., Intertek Group, Merck KgaA, Covance, Inc, GE Healthcare, QIMA LTD, Thermo Fisher Scientific, Inc., Catalent, Inc., MatTek Corporation, InVivo Biosystems, and Other Key Vendors.

New York, United States , June 14, 2024 (GLOBE NEWSWIRE) — The Global Dermal Toxicity Testing Market Size is to Grow from USD 2.27 Billion in 2023 to USD 4.95 Billion By 2033, at a Compound Annual Growth Rate (CAGR) during the projected period.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4518

Dermal toxicity testing is a type of safety assessment conducted to evaluate the potentially harmful effects of a substance when it comes into contact with the skin, intended to characterize the irritation potential, cutaneous and/or systemic toxicity associated with topical administration of compounds. It ensures consumer safety and regulatory compliance by assessing various cutaneous responses such as irritation, sensitization, and corrosion. The reconstructed human epidermis models and cell culture-based assays have gained prominence, provided accurate and reliable results while addressed ethical concerns related to animal testing. Human-derived in vitro models are mostly used in testing for local toxicity to the skin.  The field of dermal toxicity continues to evolve in order to accurately predict dermal responses in humans to topically applied chemicals. The imposition of stringent regulations and strict guidelines by regulatory bodies such as USFDA, ECHA, and ICH drive the demand for dermal toxicity testing. The increasing technological advancements have significantly improved the efficiency and effectiveness of dermal toxicity testing, propelling the market growth. On the contrary, the lack of standardized protocols and methodologies for dermal toxicity testing is restraining the global dermal toxicity testing market.

Browse key industry insights spread across 203 pages with 110 Market data tables and figures & charts from the report on the “Global Dermal Toxicity Testing Market Size, Share, and COVID-19 Impact Analysis, By Type (Product, and Services), By Testing Method (In-Vivo Testing, In-Vitro Testing, and In-Silico Modeling), By Test Type (Skin Irritation Tests, Skin Sensitization Tests, Skin Corrosion Tests, and Phototoxicity Tests), By End-Use (Healthcare Industry, Cosmetics & Personal Care Products Industry, Chemical Industry, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Buy Now Full Report: https://www.sphericalinsights.com/checkout/4518

The service segment dominates the market with the largest revenue share in 2023.

Based on type, the global dermal toxicity testing market is segmented into product and services. Among these, the service segment dominates the market with the largest revenue share in 2023. The dermal toxicity testing service segment is further divided into inhouse and outsource services. There is an expanding trend of working with CROs to outsource dermal toxicity testing and the use of cutting-edge technologies to increase the accuracy and speed of dermal toxicity testing.       

The in-vitro testing segment held the largest revenue share of the global dermal toxicity testing market in 2023.

Based on the testing method, the global dermal toxicity testing market is segmented into in-vivo testing, in-vitro testing, and in-silico modeling. Among these, the in-vitro testing segment held the largest market share of the global dermal toxicity testing market in 2023. To provide more precise predictions, in vitro testing models replicate the intricacy of human skin. The human Epidermis (RhE) model and cell culture methods are the two in vitro techniques used to classify substances as irritating or non-irritating to humans. The advancement in cell culture technologies is driving the in vitro dermal toxicity testing market.

The skin sensitization test segment dominated the global dermal toxicity testing market with the largest revenue share in 2023.

Based on the test type, the global dermal toxicity testing market is segmented into skin irritation tests, skin sensitization tests, skin corrosion tests, and phototoxicity tests. Among these, the skin sensitization segment dominated the global dermal toxicity testing market with the largest revenue share in 2023. The test for skin sensitization by dermal toxicity assesses a substance’s ability to affect the immune system to the extent that a second contact causes a more severe reaction than the first one. The increasing popularity of in vitro skin sensitization tests is driving the market growth.

The healthcare industry segment accounted for the largest market share in 2023.

Based on the end-use, the global dermal toxicity testing market is segmented into healthcare industry, cosmetics & personal care products industry, chemical industry, and others. Among these, the healthcare industry segment accounted for the largest market share in 2023. The dermal toxicity testing method is used to identify the possible health risks. Collaborations and outsourcing services are significantly contributing to the market growth in the healthcare industry segment.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/4518

North America dominates the market with the largest market share over the forecast period.

North America dominates the market with the largest market share over the forecast period. Substantial investments in the advancement of dermal toxicity testing methods are significantly contributing to the market growth. The rising demand for in-vitro dermal toxicology testing products drives the market in the region. In addition, consumer awareness and the growing emphasis on product safety are driving the market demand for dermal toxicity testing.

Asia-Pacific region is expected to grow the fastest during the forecast period. The implementation of stricter safety standards for chemicals and cosmetics by regulatory bodies across the region promotes market growth. The presence of a booming cosmetics and personal care sector, particularly in China, India, and South Korea surges the demand for dermal toxicity testing. Furthermore, the growing emphasis on research and innovation, and consumer demand for safe products are anticipated to drive the market in the region.
Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major Vendors in the Global Dermal Toxicity Testing Market are SGS S.A., Eurofins Scientific Inc, Qiagen N.V., Charles River Laboratories International, Inc., Intertek Group, Merck KgaA, Covance, Inc, GE Healthcare, QIMA LTD, Thermo Fisher Scientific, Inc., Catalent, Inc., MatTek Corporation, InVivo Biosystems, and Other Key Players.

Get Discount At @ https://www.sphericalinsights.com/request-discount/4518

Recent Developments

  • In January 2023, Eurofins Scientific expanded its presence in Indian Pharmaceutical market with new state-of-the-art Hyderabad campus, offering comprehensive services to pharmaceutical and biotech companies in the areas of synthetic organic chemistry, analytical R&D, bioanalytical services (for both large and small molecules), in-vivo pharmacology, safety toxicology and formulation R&D. The lab would provide safety toxicology testing along with other testing which would benefit company in expanding its geographical footprint.

Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global dermal toxicity testing market based on the below-mentioned segments:

 Global Dermal Toxicity Testing Market, Type Analysis

  • Product
  • Services

Global Dermal Toxicity Testing Market, Testing Method Analysis

  • In-Vivo Testing
  • In-Vitro Testing
  • In-Silico Modeling

Global Dermal Toxicity Testing Market, Test Type Analysis

  • Skin Irritation Tests
  • Skin Sensitization Tests
  • Skin Corrosion Tests
  • Phototoxicity Tests

Global Dermal Toxicity Testing Market, End-Use Analysis

  • Healthcare Industry
  • Cosmetics & Personal Care Products Industry
  • Chemical Industry
  • Others

Global Dermal Toxicity Testing Market, Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

Browse Related Reports

Global Skin Biopsy Market Size, Share, and COVID-19 Impact Analysis, By Type (Shave Biopsy, Punch Biopsy, and Excisional Biopsy, Others), By Indication (Skin Cancer, Actinic Keratosis, Dermatitis, Others), By End User (Stand-Alone Practices, Multispecialty Clinics, Hospitals, Diagnostic Centers, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Global Life Science Reagents Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Cell and Tissue Culture Reagents, Chromatography Reagents, Clinical Chemistry Reagents, Immunoassay Reagents, Molecular Diagnostic Reagents, Microbiology Reagents, and Other Product Types), By End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and Other End Users),and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.

Global Multiplex Assay Market Size, Share, and COVID-19 Impact Analysis, By Type (Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assay, and Other Multiplex Assays), By Product (Consumables and Software), By Technology (Flow Cytometry, Fluorescence Detection, Luminescenc, Multiplex Real-time PCR, & Other Technologies), By Application (R&D and Clinical Diagnostics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032.

Global Sterile Filtration Market Size, Share, and COVID-19 Impact Analysis, By Product (Cartridge Filter, Capsule Filter, Syringe Filter, and Others) By End User (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations and Research Laboratories) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) Analysis and Forecast 2022 – 2030.

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy